Nantahala Capital Management - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$7,002,000
+40.5%
300,0000.0%0.25%
+56.7%
Q3 2021$4,983,000
-31.9%
300,0000.0%0.16%
-24.5%
Q2 2021$7,317,000
-5.5%
300,0000.0%0.21%
-8.0%
Q1 2021$7,740,000300,0000.23%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders